Skip to main content
. 2022 Aug 11;10:787135. doi: 10.3389/fpubh.2022.787135

Table 3.

Consolidated health economic evaluation reporting standards checklist.

Section item Clarke et al. (7) Wang et al. (36) Sharifi et al. (40) Sjostrom et al. (38) Song et al. (13) Vestergaard et al. (19) Thakar et al. (16) Painter et al. (28) Prinja et al. (25)
Title 1 1 1 1 1 1 1 1 1
Abstract 1 0 1 1 1 1 1 1 1
Background and objectives 1 1 1 1 1 1 1 1 1
Target population and subgroups 1 0 1 1 1 0 0 0 0
Setting and location 1 1 1 1 1 1 1 0 1
Study perspective 1 1 1 1 1 1 1 1 1
Comparators 1 1 1 1 1 1 1 1 1
Time horizon 1 1 1 1 1 1 1 1 1
Discount rate 0 0 1 1 1 1 0 1 1
Choice of health outcomes 1 1 1 1 1 1 1 1 1
Measurement of effectiveness 0 0 1 1 1 1 1 1 0
Measurement and valuation of preference based outcomes 0 0 1 1 1 1 1 1 1
Estimating resources and costs 1 1 1 1 1 1 1 1 1
Currency, price date, and conversion 0 1 1 1 0 1 0 1 1
Choice of model 0 0 1 0 1 0 1 0 1
Assumptions 1 1 1 1 1 1 1 0 1
Analytical methods 1 1 1 1 1 1 1 1 1
Study parameters 1 1 1 1 1 1 1 1 1
Incremental costs and outcomes 1 1 1 1 1 1 1 1 1
Characterizing uncertainty 1 1 0 1 1 1 1 1 1
Characterizing heterogeneity 0 0 0 0 0 0 0 1 1
Study findings, limitations, generalizability, and current knowledge 1 1 1 1 1 1 1 1 1
Source of funding 1 1 1 1 1 1 0 1 1
Conflicts of interest 1 1 1 1 1 1 1 1 1
Total 18 17 22 22 22 21 19 20 22
Ratio 0.75 0.71 0.92 0.92 0.92 0.88 0.79 0.83 0.92
Quality Fair Fair Good Good Good Good Fair Good Good
Section item Levy et al. (21) Kumar et al. (22) Nguyen et al. (18) Nordyke et al. (27) O'Sullivan et al. (26) Jo et al. (23) Whetten et al. (17) Cleghorn et al. (24) Islam et al. (11)
Title 1 1 1 1 1 1 1 1 1
Abstract 0 1 1 1 1 0 1 1 0
Background and objectives 1 1 1 1 1 1 1 1 1
Target population and subgroups 1 1 1 0 1 0 0 0 0
Setting and location 1 1 1 0 1 1 1 1 1
Study perspective 1 1 1 1 1 1 1 1 1
Comparators 1 1 1 1 1 1 1 1 1
Time horizon 1 1 1 1 1 1 1 1 1
Discount rate 1 1 1 1 1 1 0 1 1
Choice of health outcomes 1 1 1 1 1 1 1 1 1
Measurement of effectiveness 1 1 1 1 1 1 0 1 1
Measurement and valuation of preference based outcomes 1 1 1 1 1 0 1 1 1
Estimating resources and costs 1 1 1 1 1 1 1 1 1
Currency, price date, and conversion 1 1 1 1 1 1 1 1 1
Choice of model 0 1 1 1 0 1 1 1 1
Assumptions 1 1 1 1 1 1 1 1 1
Analytical methods 1 1 1 1 1 1 1 1 1
Study parameters 1 1 1 1 1 1 1 1 1
Incremental costs and outcomes 1 1 1 1 1 1 1 1 1
Characterizing uncertainty 1 1 1 1 1 1 1 1 1
Characterizing heterogeneity 0 0 0 0 0 0 1 1 0
Study findings, limitations, generalizability, and current knowledge 1 1 1 1 1 1 1 1 1
Source of funding 1 1 1 1 1 1 1 1 1
Conflicts of interest 1 1 1 1 1 1 1 1 1
Total 21 23 23 21 22 20 21 23 21
Ratio 0.88 0.96 0.96 0.88 0.92 0.83 0.88 0.96 0.88
Quality Good Good Good Good Good Good Good Good Good
Section item Hoyo et al. (30) Modi et al. (39) Lowry et al. (14) Witt Udsen et al. (34) Romero-Sanchiz et al. (35) Lugo et al. (9) Oksman et al. (20) Fusco and Francesco (31) Lopez-Villegas et al. (37)
Title 1 1 1 1 1 1 1 1 1
Abstract 1 0 1 0 1 0 0 1 1
Background and objectives 1 1 1 1 1 1 1 1 1
Target population and subgroups 1 0 0 1 1 0 0 0 0
Setting and location 1 1 1 1 1 1 1 0 1
Study perspective 1 1 0 1 1 1 0 1 1
Comparators 1 1 1 1 1 1 1 1 1
Time horizon 1 1 1 1 1 1 1 1 1
Discount rate 1 1 1 1 1 0 0 1 1
Choice of health outcomes 1 1 1 1 1 1 1 1 1
Measurement of effectiveness 1 1 1 1 1 0 0 1 0
Measurement and valuation of preference based outcomes 1 1 1 1 1 1 1 1 1
Estimating resources and costs 1 1 1 1 1 1 0 1 1
Currency, price date, and conversion 1 1 1 1 1 0 0 1 1
Choice of model 0 1 1 1 1 1 0 1 0
Assumptions 1 1 1 1 1 1 0 1 1
Analytical methods 1 1 1 1 1 1 1 1 1
Study parameters 1 1 1 1 1 1 1 1 1
Incremental costs and outcomes 1 1 1 1 1 1 1 1 1
Characterizing uncertainty 1 1 0 1 1 0 1 1 1
Characterizing heterogeneity 0 0 0 1 1 1 1 1 1
Study findings, limitations, generalizability, and current knowledge 1 1 1 1 1 0 1 1 1
Source of funding 1 1 1 0 1 1 1 1 1
Conflicts of interest 1 1 0 1 1 1 1 1 1
Total 22 21 19 22 24 18 15 22 21
Ratio 0.92 0.88 0.79 0.92 1 0.71 0.63 0.92 0.88
Quality Good Good Fair Good Excellent Fair Average Good Good
Section item Wan et al. (10) Watson et al. (32) Buvik et al. (41) Oostingh et al. (12) Yoo et al. (33) Krishnan et al. (8) Bahrainwala et al. (15) de Jong et al. (29)
Title 1 1 1 1 1 1 1 1
Abstract 0 0 0 1 1 0 0 1
Background and objectives 1 1 1 1 1 1 1 1
Target population and subgroups 0 0 0 0 0 1 0 1
Setting and location 1 0 1 0 1 0 1 1
Study perspective 0 1 1 1 1 1 1 1
Comparators 1 1 1 1 1 1 1 1
Time horizon 1 1 1 1 1 1 1 1
Discount rate 0 0 1 0 1 1 1 0
Choice of health outcomes 1 1 1 1 1 1 1 1
Measurement of effectiveness 1 1 1 1 1 1 1 1
Measurement and valuation of preference based outcomes 1 1 1 1 1 1 1 1
Estimating resources and costs 1 0 1 0 1 1 1 1
Currency, price date, and conversion 1 1 0 1 1 1 1 0
Choice of model 1 1 0 1 1 1 1 1
Assumptions 1 1 1 1 1 1 1 1
Analytical methods 1 1 1 1 1 1 1 1
Study parameters 1 1 1 1 1 1 1 1
Incremental costs and outcomes 1 1 0 1 1 1 1 1
Characterizing uncertainty 0 0 1 1 1 1 1 1
Characterizing heterogeneity 1 0 0 0 0 0 0 0
Study findings, limitations, generalizability, and current knowledge 1 1 1 1 1 1 1 1
Source of funding 1 1 1 1 0 1 1 1
Conflicts of interest 1 1 1 1 1 1 1 1
Total 19 17 18 19 21 21 21 21
Ratio 0.79 0.71 0.75 0.79 0.88 0.88 0.88 0.88
Quality Fair Fair Fair Fair Good Good Good Good